Vertex Pharmaceuticals, Inc.
(NASDAQ : VRTX)

( )
VRTX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.26%165.190.7%$1305.30m
LLYEli Lilly & Co. 0.57%331.781.1%$1072.82m
ABBVAbbVie, Inc. 0.94%143.331.9%$877.03m
PFEPfizer Inc. -0.47%44.250.9%$815.29m
BMYBristol-Myers Squibb Co. 0.34%71.451.0%$767.68m
MRKMerck & Co., Inc. 0.01%88.400.7%$706.05m
AZNAstraZeneca Plc -0.54%56.731.0%$402.73m
ALNYAlnylam Pharmaceuticals, Inc. -0.11%201.028.2%$225.00m
GSKGSK Plc -1.01%30.400.3%$210.45m
NVSNovartis AG -1.11%77.360.2%$209.93m
IDXXIDEXX Laboratories, Inc. 0.44%350.123.9%$189.64m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.495.4%$183.92m
HZNPHorizon Therapeutics Plc 1.35%67.055.4%$182.38m
NVONovo Nordisk A/S 0.63%106.040.1%$132.75m
SRPTSarepta Therapeutics, Inc. -0.76%110.6212.4%$132.70m

Company Profile

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.